Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings

Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings

PURPOSE: Conversion chemotherapy is often used for borderline or unresectable (B/U) liver metastases from colorectal cancer (CRC) with the aim of achieving resectability. Although intensive and costly regimens are often used, the best regimen in this scenario remains unclear. We aimed to evaluate th...

Full description

Bibliographic Details
Main Authors:	Renata Colombo Bonadio, Paulo Henrique Amor Divino, Jorge Santiago Madero Obando, Karolina Cayres Alvino Lima, Débora Zachello Recchimuzzi, Jaime Arthur Pirola Kruger, Daniel Fernandes Saragiotto, Fernanda C. Capareli, Paulo M. Hoff
Format:	Article
Language:	English
Published:	American Society of Clinical Oncology 2019-09-01
Series:	Journal of Global Oncology
Online Access:	http://ascopubs.org/doi/10.1200/JGO.19.00180

Similar Items

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
by: Changhoon Yoo, et al.
Published: (2020-09-01)

Caracterização e efeitos do ACTH nas células progenitoras do córtex adrenal durante sua regeneração em animais UbiquitinaC-Cre/ERT2 Pomc Flox/Flox.
by: Ismael Cabral Costa
Published: (2016)

Caracterização e efeitos do ACTH nas células progenitoras do córtex adrenal durante sua regeneração em animais UbiquitinaC-Cre/ERT2 Pomc Flox/Flox.
by: Costa, Ismael Cabral
Published: (2016)

Liver Transplantation for Unresectable Metastases from Colon Adenocarcinoma
by: Luis Armando Caicedo, et al.
Published: (2017-01-01)

Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene
by: Francesca Sciandra, et al.
Published: (2017-11-01)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
by: Valiollah Mehrzad, et al.
Published: (2016-01-01)

Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma
by: Giovanni Bernardo, et al.
Published: (2009-07-01)

CHEMOEMBOLIZATION FOR UNRESECTABLE COLORECTAL LIVER METASTASES WITH DRUG-ELUTING MICROSPHERES
by: A. V. Skupchenko, et al.
Published: (2016-02-01)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
by: Hosein Peter J, et al.
Published: (2012-05-01)

Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells.
by: Jay A Gantz, et al.
Published: (2012-01-01)

Atg5flox-Derived Autophagy-Deficient Model of Pompe Disease: Does It Tell the Whole Story?
by: Jeong-A Lim, et al.
Published: (2017-12-01)

Liver transplantation for unresectable hepatic metastases from colorectal cancer: literature review
by: Nicolae BACALBASA, et al.
Published: (2019-06-01)

Gastrointestinal neuroendocrine tumor with unresectable liver metastases: an example of multimodal therapeutic approach
by: Jorge Martínez, et al.
Published: (2015-09-01)

A rapid in vitro method to flip back the double-floxed inverted open reading frame in a plasmid
by: Jian Xu, et al.
Published: (2018-08-01)

Generation and Validation of a Mouse Line with a Floxed SRC-3/AIB1 Allele for Conditional Knockout
by: Zhaoliang Liu, Lan Liao, Suoling Zhou, Jianming Xu
Published: (2008-01-01)

Substantiation of principles of combined stage treatment of patients with colon cancer with unresectable liver metastases
by: K. H. Link, et al.
Published: (2018-10-01)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
by: Luigi Rossi, et al.
Published: (2012-06-01)

The effect of the endovascular access on the effectiveness and safety of chemoembolization of the arteries of the liver with unresectable liver metastases
by: Dmitry P. Lebedev, et al.
Published: (2020-02-01)

Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience
by: Boselli C, et al.
Published: (2013-03-01)

How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective
by: Katsunori Imai, et al.
Published: (2019-09-01)

Isolated Limb Perfusion for the Treatment of Unresectable In- Transit Metastases of Cutaneous Squamous Cell Carcinoma
by: Joana Barbosa, et al.
Published: (2021-06-01)

MASTR: A Technique for Mosaic Mutant Analysis with Spatial and Temporal Control of Recombination Using Conditional Floxed Alleles in Mice
by: Zhimin Lao, et al.
Published: (2012-08-01)

Resultados oncológicos dos esquemas de quimioterapia adjuvante FLOX e FOLFOX nos pacientes com câncer colorretal
by: Frota, Cláudia Ottaiano Rodrigues
Published: (2016)

Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice
by: Yoshiko Nakagawa, et al.
Published: (2016-08-01)

Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre
by: Claudio Pizzo, et al.
Published: (2020-12-01)

Pre-clinical and clinical development of microwave ablation as a treatment for unresectable colorectal liver metastases
by: Strickland, Andrew David
Published: (2005)

Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer
by: Hung-Ming Wang, et al.
Published: (2017-03-01)

Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
by: S. E. Voskanyan, et al.
Published: (2020-12-01)

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
by: Maarten L J Smits, et al.
Published: (2013-01-01)

Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases
by: Michael J. Carr MD, MS, et al.
Published: (2020-12-01)

Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.
by: Anthony J Zacharias, et al.
Published: (2015-01-01)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with Y-Microspheres for Unresectable Liver Metastases.
by: Maarten L. J. Smits, et al.
Published: (2013-01-01)

Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases
by: Wada Y, et al.
Published: (2016-02-01)

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation
by: van Coevorden Frits, et al.
Published: (2005-11-01)

A Pitfall in the Diagnosis of Unresectable Liver Metastases: Multiple Bile Duct Hamartomas (von Meyenburg Complexes)
by: David Fuks, et al.
Published: (2009-07-01)

Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: the role of tumor size and eddy-current heating
by: Anilchandra Attaluri, et al.
Published: (2020-12-01)

Calcium-Free and Cytochalasin B Treatment Inhibits Blastomere Fusion in 2-Cell Stage Embryos for the Generation of Floxed Mice via Sequential Electroporation
by: Takuro Horii, et al.
Published: (2020-04-01)

Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease
by: Meredith A. Chabrier, et al.
Published: (2014-04-01)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with 90Y-Microspheres for Unresectable Liver Metastases
by: Maarten L. J. Smits, et al.
Published: (2013-01-01)

Combined trans-arterial embolisation and microwave ablation for the treatment of large unresectable hepatic metastases (>3 cm in maximal diameter)
by: Eliodoro Faiella, et al.
Published: (2020-01-01)